Purchase Summary

In order to access content on the FENIX Marketplace, you must have an account. You will also have access to FENIX Free updates.

The price for access is $599.00.

Account Information Already have an account? Log in here

Username

Password

Confirm Password

Work E-mail Address

Confirm E-mail Address

Occupation

Other

Full Name LEAVE THIS BLANK

Payment Information We accept all major credit cards

Card Number

Expiration Date

CVC

I want to receive updates from fenix.group.

By selecting this, I agree to receive emails from fenix.group.

Processing...

You will be redirected to view the full article after purchasing. You will receive your account and payment information in a confirmation email, and can be viewed at any time in your Account.

RETURN TO HOME

$599

Basal Insulin, Bolus Insulin

April 10, 2019

New Sanofi Insulin Savings Program

Here is a brief preview of this blast: Sanofi announced that it has increased the benefits to its Valyou insulin savings program to now offer up to 10 boxes of SoloStar insulin pens and/or 10 vials of 10mL insulin for $99 per month. Previously each 10 mL vial was $99 and each box of SoloStar pens was $149. According to the press release, the program covers all Sanofi insulins (Lantus, Toujeo, Admelog, and Apidra) but not Soliqua. The program will become available starting in June 2019. Below, FENIX provides brief thoughts on the program in the context of the ongoing drug pricing debate.

About The Author

Matthew Maryniak

President of Fenix Group International

Matthew has been a thought leader in the high-growth therapeutic areas of diabetes and cardiovascular medicine since 2006, making regular attendance at large and small CV/met scientific meetings and an architect of novel methods for assessing market opportunities. He has over a decade of experience in leading CV/met consulting engagements, is a published author in PM360 and Diabetes Technology & Therapeutics, and has been quoted in The Pink Sheet on anti-thrombotics.